ScripAlzheimer’s disease is top of mind due to the millions of people in need of effective treatments and the rapid rise in the AD population globally – and because the first disease-modifying therapy has
ScripMorningside Ventures launched Adiso Therapeutics on 10 March with more than $60m invested to date in the Concord, MA-based start-up focusing on the underlying biology of inflammatory diseases without
ScripThe summer of 2020 has been a busy one for US biopharmaceutical company initial public offerings, but after 14 in June and 12 in July there were just six in August – although that’s still the third mo
ScripAs the People's Republic of China celebrates the 70th birthday of its foundation and President Xi Jinping vows to strengthen communist rule, many are worrying that any increased dominance of state-own